Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

148
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
148
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

165
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
165
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

164
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
164
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

136
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
136
Cellulose and Pectic Polysaccharides01:15

Cellulose and Pectic Polysaccharides

3.5K
 Every plant cell has a cell wall that protects the cell, provides structural support, and gives the cell shape. Cellulose, the main structural component of the plant cell wall, makes up over 30% of plant matter. It is the most abundant organic compound on earth.  Cellulose is an unbranched polysaccharide composed of linear chains of glucose molecules linked by β (1→4) glycosidic bonds.
As a cell matures, its cell wall specializes according to its type. For example, the...
3.5K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

294
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
294

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolomic Analysis of <i>Heliopsis longipes</i> Roots Across Phenological Stages.

Molecules (Basel, Switzerland)·2026
Same author

Omega Fatty Acid and Protein Profiles of Colostrum and Transitional Milk in Mexican Women With and Without Gestational Diabetes: A Cross-Sectional Study.

Nutrients·2026
Same author

Biostimulation of Tomato Plants (<i>Solanum lycopersicum</i> L.) Using Fragmented Extracellular DNA from <i>Clavibacter michiganensis</i>.

Plants (Basel, Switzerland)·2026
Same author

Prefrontal Cortex Dysregulation of Amino Acid-Glucose Homeostasis Links High-Fat and/or High-Fructose Intake to Cognitive Deficits in Male Mice.

Neurochemical research·2026
Same author

Dietary Capsiate-Producing Chili Pepper Promotes Somatic and Femoral Growth and Modulates Intestinal Immunometabolic Responses in Mice.

Molecules (Basel, Switzerland)·2026
Same author

The consumption of a diet high in fat and fructose induces sex-specific alterations in the expression of key genes related to insulin synthesis, inflammation and apoptosis in the pancreatic <i>β</i>-cells of rodents.

The British journal of nutrition·2026

Related Experiment Video

Updated: May 30, 2025

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
14:39

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Published on: April 22, 2022

3.8K

Polyphenolic Compounds in Fabaceous Plants with Antidiabetic Potential.

Lucia Guerrero-Becerra1,2, Sumiko Morimoto3, Estefania Arrellano-Ordoñez1

  • 1Center of Applied Research in Biosystems (CARB-CIAB), School of Engineering, Autonomous University of Querétaro-Campus Amazcala, Carr. Amazacala-Chichimequillas km 1.0, El Marqués, Querétaro 76265, Mexico.

Pharmaceuticals (Basel, Switzerland)
|January 25, 2025
PubMed
Summary

Leguminous plants rich in phenolic compounds show promise as natural alternatives for managing diabetes mellitus (DM). These natural supplements offer antioxidant and hypoglycemic benefits, potentially reducing reliance on traditional antidiabetic medications.

Keywords:
antioxidantdiabeteslegumesphytochemicalssecondary metabolites

More Related Videos

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
12:00

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Published on: July 5, 2017

19.1K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

1.9K

Related Experiment Videos

Last Updated: May 30, 2025

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
14:39

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Published on: April 22, 2022

3.8K
Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
12:00

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Published on: July 5, 2017

19.1K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

1.9K

Area of Science:

  • Nutritional Science
  • Pharmacology
  • Endocrinology

Background:

  • Diabetes mellitus (DM) is a growing global health concern with serious complications.
  • Current oral hypoglycemic drugs for DM can cause adverse effects.
  • Natural supplements are explored as adjunct therapies to improve DM management and patient quality of life.

Purpose of the Study:

  • To review leguminous plants with anti-diabetic properties.
  • To highlight the role of phenolic compounds in these plants.
  • To assess their potential as natural alternatives for diabetes treatment.

Main Methods:

  • Literature review of studies on leguminous plants and their anti-diabetic effects.
  • Analysis of in vitro and in vivo research on antioxidant, hypoglycemic, and protective properties.
  • Focus on phenolic compound content and mechanisms of action.

Main Results:

  • Leguminous seeds, high in phenolic compounds, exhibit significant antioxidant and hypoglycemic activities.
  • These compounds show potential in improving insulin synthesis, secretion, and pancreatic islet cell function.
  • Demonstrated in vitro and in vivo benefits include anti-fat-induced damage and anti-apoptotic effects.

Conclusions:

  • Leguminous plants offer promising natural alternatives for diabetes management due to their phenolic compounds.
  • These natural products can serve as complementary therapies, potentially reducing the need for conventional medications.
  • Further research is required to determine optimal dosages, efficacy, and safety in human populations for clinical integration.